Meta-analyses of multiple studies have shown significant correlations between ADC values and hormone receptor status in breast cancers: Estrogen receptor (ER)-positive and progesterone receptor (PR)-positive cancers generally exhibit lower ADCs than their negative counterparts. This evidence concerns the gene NR4A1 and breast carcinoma.